Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Gross Margin (2016 - 2025)

Historic Gross Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 60.3%.

  • Ekso Bionics Holdings' Gross Margin rose 68000.0% to 60.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.48%, marking a year-over-year increase of 16400.0%. This contributed to the annual value of 53.06% for FY2024, which is 33900.0% up from last year.
  • Ekso Bionics Holdings' Gross Margin amounted to 60.3% in Q3 2025, which was up 68000.0% from 39.82% recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Gross Margin peaked at 64.66% during Q1 2021, and registered a low of 39.82% during Q2 2025.
  • Moreover, its 5-year median value for Gross Margin was 53.27% (2024), whereas its average is 52.64%.
  • In the last 5 years, Ekso Bionics Holdings' Gross Margin soared by 212700bps in 2021 and then crashed by -175600bps in 2022.
  • Over the past 5 years, Ekso Bionics Holdings' Gross Margin (Quarter) stood at 59.25% in 2021, then decreased by -20bps to 47.25% in 2022, then rose by 3bps to 48.88% in 2023, then grew by 9bps to 53.32% in 2024, then increased by 13bps to 60.3% in 2025.
  • Its last three reported values are 60.3% in Q3 2025, 39.82% for Q2 2025, and 53.51% during Q1 2025.